Additional highlights from the ASRS Preferences and Trends Survey include:
• 10.8 percent of respondents in the United States and Canada now report that they would use Eylea as first-line therapy for subfoveal CNV due to AMD
• 67 percent follow a treat-and-extend protocol in the management of wet AMD
More Articles on Eye Surgery:
Ophthalmologist Dr. George Primbs Recognized for Community Service
5 Ophthalmologists on Where Eye Surgery is Headed
Retina Specialist Dr. Hyung Cho Joins Georgia Retina in Stockbridge
